Ryan Specialty Holdings, Inc. (NYSE:RYAN – Get Free Report) EVP Brendan Martin Mulshine sold 30,000 shares of the company’s stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $69.30, for a total transaction of $2,079,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Ryan Specialty Stock Performance
RYAN traded up $1.46 on Monday, reaching $71.33. 932,226 shares of the stock were exchanged, compared to its average volume of 905,859. The company’s 50-day moving average price is $67.11 and its 200 day moving average price is $67.76. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The firm has a market capitalization of $18.68 billion, a PE ratio of 103.38, a PEG ratio of 1.19 and a beta of 0.71. Ryan Specialty Holdings, Inc. has a fifty-two week low of $48.48 and a fifty-two week high of $75.97.
Ryan Specialty (NYSE:RYAN – Get Free Report) last announced its quarterly earnings data on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.02). The business had revenue of $663.53 million for the quarter, compared to analyst estimates of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. As a group, sell-side analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.
Ryan Specialty Increases Dividend
Analysts Set New Price Targets
RYAN has been the subject of a number of analyst reports. Barclays upped their price objective on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research note on Thursday, November 21st. Royal Bank of Canada lowered their price target on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating on the stock in a report on Friday, February 21st. UBS Group lifted their price objective on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a “buy” rating in a research report on Wednesday, February 26th. Keefe, Bruyette & Woods decreased their target price on shares of Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating for the company in a research report on Friday, February 21st. Finally, Morgan Stanley started coverage on shares of Ryan Specialty in a report on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price target on the stock. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $75.27.
Read Our Latest Report on Ryan Specialty
Institutional Trading of Ryan Specialty
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Assetmark Inc. purchased a new position in Ryan Specialty during the third quarter worth approximately $34,000. Crossmark Global Holdings Inc. purchased a new position in shares of Ryan Specialty during the 3rd quarter valued at approximately $475,000. CIBC Asset Management Inc purchased a new position in shares of Ryan Specialty during the 3rd quarter valued at approximately $231,000. Natixis Advisors LLC acquired a new stake in Ryan Specialty in the 3rd quarter valued at $2,021,000. Finally, Premier Fund Managers Ltd increased its holdings in Ryan Specialty by 59.4% in the 3rd quarter. Premier Fund Managers Ltd now owns 10,994 shares of the company’s stock worth $726,000 after acquiring an additional 4,098 shares in the last quarter. Institutional investors and hedge funds own 84.82% of the company’s stock.
Ryan Specialty Company Profile
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Articles
- Five stocks we like better than Ryan Specialty
- There Are Different Types of Stock To Invest In
- Can TikTok Stock Picks Really Make You Rich?
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- The “Quality” Rotation: Back to Basics Investing
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.